Teleflex Incorporated (NYSE:TFX) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Teleflex Incorporated (NYSE:TFXGet Free Report) have earned an average rating of “Hold” from the eleven ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $148.00.

TFX has been the topic of several research analyst reports. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and increased their target price for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $140.00 to $160.00 in a research note on Monday, June 8th. BMO Capital Markets started coverage on shares of Teleflex in a research report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price target for the company. Finally, Raymond James Financial reissued an “outperform” rating and issued a $150.00 price target on shares of Teleflex in a research note on Friday, May 8th.

Check Out Our Latest Analysis on TFX

Institutional Trading of Teleflex

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. acquired a new position in Teleflex during the second quarter worth $1,391,000. GAMMA Investing LLC grew its stake in shares of Teleflex by 60.7% in the second quarter. GAMMA Investing LLC now owns 839 shares of the medical technology company’s stock valued at $106,000 after buying an additional 317 shares in the last quarter. Versant Capital Management Inc grew its stake in shares of Teleflex by 573.4% in the second quarter. Versant Capital Management Inc now owns 431 shares of the medical technology company’s stock valued at $55,000 after buying an additional 367 shares in the last quarter. Glenmede Trust Co. NA grew its stake in shares of Teleflex by 42.1% in the first quarter. Glenmede Trust Co. NA now owns 6,867 shares of the medical technology company’s stock valued at $821,000 after buying an additional 2,036 shares in the last quarter. Finally, Bank of America Corp DE raised its holdings in shares of Teleflex by 6.4% in the 1st quarter. Bank of America Corp DE now owns 445,958 shares of the medical technology company’s stock valued at $53,341,000 after buying an additional 27,004 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE:TFX opened at $135.24 on Thursday. Teleflex has a 52 week low of $100.18 and a 52 week high of $139.67. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $5.99 billion, a P/E ratio of -5.93, a P/E/G ratio of 1.00 and a beta of 0.82. The stock’s fifty day moving average is $130.79 and its two-hundred day moving average is $120.74.

Teleflex (NYSE:TFXGet Free Report) last announced its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.21 by $0.18. The business had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company’s quarterly revenue was up 32.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities analysts expect that Teleflex will post 6.7 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is -5.96%.

About Teleflex

(Get Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Further Reading

Analyst Recommendations for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.